Malin Corporation | MLC - Net Income

Stock Price
7.95
Daily Change
0.10 1.27%
Monthly
3.25%
Yearly
-22.06%
Q1 Forecast
7.76

Malin Corporation reported EUR-1.1M in Net Income for its fiscal semester ending in December of 2023.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 417K Sep/2025
ALKERMES USD 82.76M 4.34M Sep/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Eurofins Scientific SE EUR 216M 29.8M Jun/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
IQVIA Holdings USD 331M 65M Sep/2025
Lonza CHF 307M 22M Dec/2024
Malin Corporation EUR -1.1M 2.2M Dec/2023
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Viatris USD -128.2M 123.6M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025